Folding@home
  • Download
  • Science
    • Covid-19
    • Diseases
    • Project Timeline
    • Papers & Results
    • Dig deeper
  • Support
    • User Guides
    • FAQ
    • Forum đź”—
    • Discord đź”—
  • Donate
    • USD via Folding@home Foundation đź”—
    • Crypto via Folding@home Foundation đź”—
    • DAF via Folding@home Foundation đź”—
    • Merchandise store đź”—
  • Data
  • Statistics
  • News
  • About
    • Gregory Bowman, PhD
    • The Folding@home Consortium (FAHC)
    • Contact us

Archives

Categories

  • Cancer
    • Breast Cancer
    • Epigenetics
    • Kidney Cancer
    • p53
  • Community
  • FAH achievements
  • FAH network connectivity
  • FAH team members
  • Folding@Home
  • Folding@home Blog
    • Meet the classic paper
  • General
  • Heads up
  • How FAH works
  • Infectious diseases
    • Chagas Disease
    • COVID-19
  • Neurological diseases
    • Alzheimer’s Disease
    • Huntington’s Disease
    • Parkinson’s Disease
  • Papers
  • Science
  • Software development
  • Timeline
  • Uncategorized
  • Web/Tech

Category: Breast Cancer

Understanding epigenetic cancer targets with Folding@home: Histone methyltransferases NSD1, NSD2, and NSD3

October 26, 2016 by Rafal Wiewiora

The Chodera Lab at the Memorial Sloan Kettering Cancer Center is now running a series of projects to study the conformational dynamics of histone methyltransferases to aid in the rational design of new small molecule…

Read more

Fighting cancer on Folding@home: FDA approved kinase inhibitors

December 26, 2014 by Sonya Hanson

You may have noticed a trend in the type of proteins being simulated on Folding@home recently. A number of Folding@home labs are collaborating in an attempt to understand the role…

Read more

Breast Cancer and Her2 Kinase: Projects 9104-9114

November 20, 2014 by Vijay Pande

We are continuing to make a big push into studying cancer. Next up, is work relevant for breast cancer. Specifically, we have started to study the Her2 Kinase, a part…

Read more

New projects to help design selective inhibitors of protein methyltransferases

October 20, 2014 by John Chodera

The Chodera lab has teamed up with Luo lab at MSKCC to study another important class of cancer targets: protein methyltransferases. These are protein-modifying enzymes that catalyze the transfer of…

Read more

Fighting cancer on Folding@Home: EGFR

January 14, 2014 by John Chodera

[Guest post by Daniel L. Parton of the Chodera Lab, Memorial Sloan-Kettering Cancer Center.] We’re about to roll out our first major F@h project on the new work server at…

Read more